Different pharmaceutical manufacturing processes have been demonstrated to represent feasible platforms for the production of pharmaceutical cocrystals. However, new methods are needed for the manufacture of cocrystals on a large scale. In this work, the suitability of the use of a fluidized bed system for granulation and concomitant cocrystallization was investigated. Dapsone (DAP) and caffeine (CAF) have been shown to form a stable cocrystal by simple solvent evaporation. DAP is the active pharmaceutical ingredient (API) and CAF is the coformer. In the present study, DAP-CAF cocrystals were produced through liquid-assisted milling and the product obtained was used as a cocrystal reference. The granulation of DAP and CAF was carried out using four different experimental conditions. The solid-state properties of the constituents of the granules were characterised by differential scanning calorimetry (DSC) and x-ray powder diffraction (PXRD) analysis while the granule size distribution and morphology were investigated using laser diffraction and scanning electron microscopy (SEM), respectively. DAP-CAF cocrystal granules were successfully produced during fluidized bed granulation. The formation of cocrystals was possible only when the DAP and CAF were dissolved in the liquid phase and sprayed over the fluidized solid particles. Furthermore, the presence of polymers in solution interferes with the cocrystallization, resulting in the amorphization of the DAP and CAF. Cocrystallization via fluidized bed granulation represents a useful tool and a feasible alternative technique for the large scale manufacture of pharmaceutical cocrystals for solid dosage forms.
INTRODUCTION
A variety of different manufacturing operations are commonly employed in the pharmaceutical industry, with most based on the application of mechanical and thermal energies and many also involving the use of different types of aqueous or non-aqueous solvents. The impact of process variables on the raw materials can significantly influence the quality of a final solid dosage form. Under stress conditions, many active pharmaceutical ingredients (APIs) have shown a tendency to change from the initial solid form to their related polymorphs. Process-related phase transformations have been reported for many of the most extensively used manufacturing processes such as compression, milling, hot melt extrusion, granulation and drying (1) (2) (3) (4) (5) .
Polymorphism constitutes the existence of different crystalline habits for the same compound and is a very commonly observed phenomenon for APIs. The disorganised arrangement of molecules without a defined crystal lattice (amorphous form) and the presence of solvent molecules in the crystal lattice (solvates and hydrates) may also be considered as polymorphic or pseudopolymorphic forms (6) . However, different crystal structures of the same drug may present important differences in physiochemical properties, bioavailability and pharmacological activities (7) (8) (9) . In this sense, understanding and controlling the process variables which can potentially induce changes in the solid state of the API during pharmaceutical manufacturing is critical to guaranteeing the quality and safety of the final medicinal product.
APIs may be classified under the Biopharmaceutics Classification System (BCS) guidelines into four BCS classes, based on their ability to dissolve in water and permeate human tissues. The APIs that are classified as class II (high permeability and low solubility) and IV (low permeability and low solubility) are characterised by their low aqueous solubility (10) . The variable or inadequate bioavailability of many new promising pharmaceutical compounds is frequently due to their poor water solubility (11) . For this reason, the improvement in drug solubility represents a major challenge for scientists.
Different polymorphic forms of the same API can significantly differ in solubility from each other, and amorphous forms are characterised by higher solubility than crystalline forms due to the absence of an ordered crystal lattice (12) . However, the amorphous state is inherently less physically stable than the crystalline counterpart, with molecules in the amorphous state showing a tendency to organise themselves into a more stable crystalline habit over time, making the application of the amorphous state in pharmaceutical solid dosage forms challenging for the majority of APIs (13) .
A strategy to overcome solubility and stability issues for drugs with low water solubility is to explore the possibility of forming cocrystals (14) . The coexistence in the same crystal habit of two or more different molecules (API and coformer) generates a new chemical entity which can present different properties to the parent compounds, often including different solubility. In order to produce cocrystals, diverse strategies have been employed including the use of different crystallisation from solution techniques (15, 16) and manufacturing processes such as milling (17, 18) , hot melt extrusion (19, 20) and spray drying (21, 22) . In the case of pharmaceutical processing techniques such as milling, hot melt extrusion and spray drying, while such processes may inadvertently lead to solid-state transformations such as polymorphic changes or amorphisation of API, in the case of cocrystallization, the energy input of the process is directed to deliberately inducing interaction between cocrystal components.
Fluidized bed granulation is a further manufacturing process that is widely used in the pharmaceutical industry. In the fluidized bed chamber, fluidization of the raw materials is induced through a gas flow, while a solution is sprayed on the fluidized particles generating agglomeration and an increase in particle size (23) . The possibility of mixing, granulating and drying in a single unit, reducing the loss of materials during transfer, with low labour costs and short production times have made this technique very convenient and widely used in the industry. Polymorphic transformations during wet granulation (1, 24, 25) and during drying in a fluidized bed system (2) were previously reported. The use of solvents in combination with mechanical stress and the increase of temperature during the drying phase represent the main factors inducing phase transformation of APIs (26) . Thus, we hypothesise that, if fluidized bed processing can induce polymorphic transformations, it may also be used to purposefully induce cocrystallization.
In this study, the production of granules containing pharmaceutical cocrystals via fluidized bed granulation in a one-step process was investigated. An evaluation of the role of the process variables during the manufacturing process was carried out through a series of four different experimental conditions. The influence of mechanical and thermal energy, solvent composition, polymers and presentation of the co-crystal components (as a solution or in the solid phase) was assessed.
We recently reported on the production of a dapsonecaffeine (DAP-CAF) cocrystal by spray drying and liquidassisted milling (27) . Dapsone is a BCS class II drug, the solubility of which can be significantly improved by cocrystallisation using caffeine as the coformer (27, 28) . This cocrystal was considered a useful model to probe the applicability of fluidized bed granulation (FBG) processing as an alternative, scaleable, in situ cocrystallization production technique for solid dosage forms. 
MATERIALS AND METHOD

Materials
Granules Preparation
A fluidized bed system (Mini Glatt with Micro-kit, Glatt, Binzen, Germany) was employed to produce 5 g of granule batches containing 60% w/w of DAP and CAF, 35% w/w of filler, and 5% w/w of binder excipient. The DAP/CAF molar ratio was kept constant (1:1 M ratio) for all the experiments performed. Corn starch or MCC, and PVP or HPMC, were used as filler materials and binder, respectively. The granulation was conducted using four different experimental conditions (EXP) where the inlet temperature and the composition of the liquid and the solid phase were changed, as detailed in Table I . The solid particles were fluidized at 20 m 3 /h nitrogen flow rate and then 10 ml of solution was sprayed at 0.5 bar of pressure with a peristaltic pump set at 0.5 ml/min using the bottom spray mode. The inlet temperature was maintained constant for both granulation and drying phases ( Table I) .
Preparation of Reference Cocrystals
Liquid-assisted grinding was employed to prepare 1:1 M ratio DAP-CAF cocrystals using a laboratory ball mill (Cryomill, Retsch) (27) . Briefly, 561 mg of DAP and 439 mg of CAF were accurately weighed and placed in a 25-ml stainless steel jar containing three stainless balls (Ø = 10 mm) and, after the addition of 200 μl of acetone, milling was carried out at 30-Hz frequency for 30 min at room temperature. The processed materials were subsequently dried under vacuum in an oven at 40°C for 6 h.
Differential Scanning Calorimetry
The samples were analysed using a Q200 MDSC (TA Instruments, Leatherhead, UK) equipped with a refrigerated cooling system (RCS-90) and purged with inert dry nitrogen gas at a flow rate of 50 ml/min. Indium standard was used for temperature and melting enthalpy calibration and validation.
The samples were hermetically sealed in a TA instruments standard aluminium pan and lid and heated from 30 to 240°C at 10°C/min heating rate. The data were acquired and analysed using Thermal Advantage and Universal Analysis software (version 4.4, TA Instruments, Leatherhead, UK), respectively. The analysis was performed in triplicate.
Powder X-ray Diffraction Analysis
Powder x-ray diffraction analysis (PXRD) was performed in reflection mode using a benchtop X-ray diffraction instrument Rigaku Miniflex II (Rigaku, Tokyo, Japan) equipped with a CuKα x-ray source and Haskris cooling unit (Grove Village, IL, USA). The samples were front-loaded by gently pressing using a glass slide on a zero-background silicon sample holder. The PXRD patterns were recorded for 2θ ranging from 3°to 40°with a step scan rate of 0.05°per second. The analysis was performed in triplicate.
Particle Size Analysis
Particle size distribution of the granules was measured by the dry method in a laser diffraction particle size analyser (Mastersizer 2000, Malvern Instruments Ltd., Worcestershire, UK) equipped with a Scirocco 2000 dry powder feeder unit with 2 bar pressure and feed rate of 25%. Analyses were undertaken using a real part refractive index of 1.54 and an absorption part of 0.01. Malvern Masterizer 2000 software was used to determine the d(0.1), d(0.5) and d(0.9) values, which are the particle sizes corresponding to the 10, 50 and 90% points of the cumulative distribution curve, respectively. The d(0.5) is the median particle size of the volume distribution. The width of the size distribution was expressed by the span value, calculated from the d values as follows (Eq. 1):
Scanning Electron Microscopy
The surface and morphology of the granules were analysed by scanning electron microscopy (SEM) using a Zeiss Supra Variable Pressure Field Emission Scanning Electron Microscope (Supra Series, Oberkochen, Germany) equipped with a secondary electron detector at 5 kV. The samples were glued onto aluminium stabs and sputter-coated with gold-palladium under vacuum prior to analysis. SEM photographs were taken at ×50 magnification.
Flow Properties
The compressibility, stability and variable flow rate were investigated using the FT4 powder rheometer (Freeman Technology Ltd., Worcestershire, UK). The compressibility was expressed as the percentage change in volume of the conditioned bulk powder, measured at increasing applied normal stresses from 1 to 15 kPa (1, 2, 4, 6, 8, 10, 12, and 15 kPa).
The energy required to rotate the blade downward through the powder sample in a 25-ml cylindrical vessel was recorded seven times at a blade speed of 100 mm/s for the stability index test. The blade speed was decreased stepwise from 100 to 10 mm/s (100, 70, 40, 10 mm/s) to measure the impact of variable flow rate on powder flow properties. The stability index (SI) (Eq. 2) and flow rate index (FRI) (Eq. 3) were calculated from the measured powder flow energy:
Shear cell analysis was performed using a 1-ml shear cell module. The sample of granules was conditioned using the conditioning wire and precompressed at 9 kPa consolidation stress by a vented piston. The standard shear cell test program was used to perform shear cell analysis using a shear cell head accessory (29) . The shear test measures the shear stress needed to obtain a failure of the powder, i.e. the powder particles start to move relative to one another, as a function of the applied normal stress. The yield locus is a plot of normal vs shear stress (kPa), generated for bulk solid samples consolidated at 9 kPa. Cohesion (kPa) and effective angle of internal friction (AIF (E)) were calculated from best fitting of the yield locus and flow function coefficient (ffc) was calculated from Mohr circle analysis of the best fit of the plot (29) .
RESULTS AND DISCUSSION
Polymorphic phase transformations during manufacturing operations are usually associated with an increase in free energy of the system generated by different types of stress (30) . In this sense, stress refers to any physical change that is able to move the system from or toward the equilibrium (31). During fluidized bed drying granulation, the dispersed solid phase is subjected to mechanical stress due to the attrition generated by particle-particle and particle-wall collisions. Furthermore, the mechanical stress combined with the presence of solvents and the use of high temperatures during the drying phase can induce polymorphic transformations (32) . However, stress factors are also involved in the crystallisation pathways for the production of cocrystals (33) . Solvent-assisted milling is a highly efficient technique for cocrystallization through a mechanochemical reaction between the parent compounds (API and coformer) in the presence of catalytic amounts of a liquid phase (34) . The DAP-CAF cocrystal was successfully prepared by means of a slow-evaporative crystallisation technique and structurally characterised in previous work (27, 28 ). In the current study, DAP-CAF cocrystals were obtained by milling the parent compounds (API and coformer) for 30 min using a small amount of acetone, in a similar manner to that recently described (27) . The DSC analysis of DAP-CAF cocrystal shows a single endothermic event related to the cocrystal melting at 176.4°C and an absence of thermal events related to the melting of DAP and CAF at 178.5°and 237.5°, respectively (Fig. 1i) . Both DAP and CAF raw materials present a solid mediated phase transformation in the DSC, at 82.6°C and at 158.7°C, respectively. The absence of these thermal events after milling and the presence of a single melting endotherm which is consistent with that previously reported for the cocrystal (27, 28) confirms the formation of the DAP-CAF cocrystal. Furthermore, the PXRD analysis for DAP-CAF cocrystal shows differences in crystalline diffraction patterns compared to the parent compounds, presenting new diffraction peaks at 2θ values of 11°, 14.1°, 16.2°, 22.9°and 25.4° (Fig. 1ii) , consistent with literature data for the cocrystal (28) .
Fluidized bed granulation of DAP and CAF was carried out using four experimental conditions where the most significant difference between experimental procedures was the physical state in which the API and coformer were presented to the fluidized bed system. In the first and the second sets of the experimental series (EXP 1 and 2, Table I ), DAP and CAF were suspended as solid particles, while in the third and fourth sets of the experimental series (EXP 3 and 4, Table I ) DAP and CAF were dissolved in the liquid phase.
In EXP 1, the solid phase was composed of DAP, CAF and the filler excipient while the binder was dissolved in a water/acetone solution. The process was conducted at two different temperatures (60 and 80°C) with a view to determining the impact of granulation and drying temperature on the solid-state form of the final product. The solidstate characterisation of the granules obtained under these conditions shows an unaltered crystalline form for both DAP and CAF compared to the starting materials. The DSC analysis for EXP 1 granules shows no solid-state form change for either compound (Fig. 2i) . The PXRD patterns for the EXP 1 granules confirm that DAP and CAF maintain the same crystalline form as the unprocessed materials (Fig. 2ii) .
In the fluidized bed dryer, the high inlet temperatures used during the granulation can lead to an increased solvent evaporation rate from the wetted particles, decreasing the possibility of solvent-related phase transformations during the process (35).
The particle size distribution analysis for the unprocessed materials and the granules produced are reported in Tables II  and III , respectively. It is well-known that the solution viscosity decreases when the inlet temperature increases, reducing the droplet size and promoting the growth of smaller granules during the granulation process (36) . In fact, several studies report a linear relationship between granule and droplet sizes in fluidized bed granulation (37) (38) (39) . However, contrary to expectation, in this study, large granules were obtained when a higher inlet temperature (80°C) was used. It is possible that, for small batches, the influence of inlet temperature on granule size is not as relevant as in large-scale processing. The largest granules were obtained when HPMC was used as binder at 80°C inlet temperature. The granules produced using MCC and corn starch as filler excipient had d(0.5) values of 206 and 208 μm, respectively.
In EXP 2, all the formulation components were suspended as solid particles in the fluidized bed dryer while pure acetone was employed as a wetting agent. The ability of the pure solvent to induce DAP-CAF cocrystallization during the granulation process was investigated. The DSC (Fig. 3i ) and PXRD analysis (Fig. 3ii) show no changes in the solidstate of DAP and CAF and no evidence of the formation of DAP-CAF cocrystals. The particle size analysis indicates a heterogeneous particle size distribution for the samples after the FBG process (Table IV) . Acetone evaporates faster than water/acetone (50:50) (which was used in EXP 1) and does not permit sufficient cohesion between particles. Usually, when the binder is present as solid particles, the process leads to the formation of bigger granules (40) but, due to the low solubility of the binder in pure acetone, the formation of granules is compromised (41) . Furthermore, water also has a binder function during FBG processing, improving nucleation and coalescence between agglomerates (42,43).
The API and coformer were dissolved in water/acetone (50:50) during the granulation under EXP 3 conditions and the solution was sprayed over the fluidized particles constituted from binder and filler. The DSC analysis of the granulated samples suggests the formation of DAP-CAF cocrystals in the granules produced (Fig. 4i) . A single endothermic event related to the melt of DAP-CAF cocrystal at 175°C and the absence of the characteristic DAP solidsolid phase transition at 83°C support the formation of DAP-CAF cocrystals. The PXRD analysis of the granules produced shows the presence of characteristic diffraction peaks for the DAP-CAF cocrystal (Fig. 4ii) . The complete dissolution of the API and coformer in a common solvent system, followed by the spraying/drying of the solution permitted in situ cocrystallization during the granulation process in the fluidized bed system The mechanism of formation is likely to be similar to that of cocrystal formation in a spray drying process, although the rate of solvent evaporation is likely to be slower in a fluidized bed system which typically operates at lower drying temperatures. When the API and coformer are co-spray dried, the fast solvent evaporation from the droplets promotes the formation of cocrystals (21) . The particle size distribution analysis shows good homogeneity and increased particle size for the granules prepared using MCC as filler (Table V) . On the other hand, the samples prepared using starch demonstrated poor granule growth, probably due to low particle cohesion under these conditions. In the EXP 4 series, API, coformer and binder were all dissolved in water/acetone (50:50) and then sprayed over the fluidized solid phase constituted by the filler excipient. The thermal analysis performed on the granules shows a broad endothermic peak from 25°C to approximately 125°C for samples prepared using MCC and from 25°C to approximately 145°for samples prepared using starch (Fig. 5i) , which is probably due to the loss of residual moisture from the granules (44) . The granules produced using HPMC as binder show an exothermic event overlapping with a broad endotherm indicating crystallisation of amorphous material, followed by a sharp endothermic peak at 173°C due to melting. On the other hand, the thermal analysis of granules produced using PVP show no exothermic events. Furthermore, small endothermic events are observed at T onset = 157°C for starch-PVP granules and at T onset = 156°and 178°C for MCC-PVP granules.
The PXRD analysis of the EXP 4 granules shows a significant decrease in crystallinity (relative to cocrystals prepared by milling) for all the samples produced, suggesting amorphization of the DAP and CAF during the granulation process (Fig. 5ii) . The presence of polymeric binder in solution with the starting compounds inhibits the formation of a crystal lattice after the evaporation of the dissolving solvent. Consequently, the production of an amorphous phase from polymeric solutions is favoured. Similarly, an amorphous solid dispersion of nifedipine-HPMC on sugar spheres was previously prepared using a fluidized-bed system (45) . Crystalline peaks of low intensity for CAF at a 2θ value of 11.8°and DAP-CAF cocrystal at a 2θ value of 26.7°C indicate the presence of residual amounts of crystalline compounds.
The MCC-PVP granules show a significant increase in particle size (relative to starting materials) and homogenous particle size ranging between 110 (d0.1) and 297 μm (d0.9) with low span values (Table VI) . Other samples prepared in The photomicrographs of the granules produced in EXP 1-4, which demonstrated the most significant size increase compared with the raw materials, are shown in Fig. 6 . The granules produced under EXP 1-4 conditions are characterised by irregular shapes and rough surfaces. The EXP 2 samples show poor granule formation, presumed to be due to the fast evaporation rate of acetone during the process.
Flow properties studies were not performed on EXP 2 samples due to the failure in granulation and cocrystallization during the granulation process.
The granules obtained from EXP 3 and 4 were found to have a SI of 0.94 and 0.98, respectively, during the dynamic flow test (Table VII) . Values between 0.9 and 1.1 indicate good stability of the powder without agglomeration tendency during handling and storage. On the other hand, EXP 1 granules showed an SI value of 0.87, indicating instability of the sample, probably due to attrition/de-agglomeration of the granules during the test.
The flow rate index (FRI) is a dimensionless quantity which describes the powders sensitivity to flow rate changes. Values of FRI ranging between 1.5 and 3 are common for most powders, while FRI > 3 are associated with cohesive powders which are highly sensitive to flow rate, and a value of FRI ≈ 1 is usually related to powders which are insensitive to flow rate changes, characterised by large particle size or surface treatments. As expected, the dynamic powder flow at variable blade tip speed data indicated a decrease in the FRI values for all the granules compared with the raw materials, indicating that the granules are less sensitive to the flow rate changes and their flowability is higher than the unprocessed materials. However, comparing the FRI value obtained for the different granules produced, EXP 4 granules were shown to have a FRI of 1.39, while EXP 3 and EXP 1 had FRIs of 1.30 and 1.08, respectively. The samples also showed differences in compressibility for normal stress values ranging between 1 and 15 kPa (Fig. 7) . The granules obtained in EXP 4 demonstrated a higher compressibility compared to the granules prepared in EXP 1 (approx. 40% greater) and 3 (approx. 70% greater). Cohesive powders and granules with poor flow properties are more sensitive to volume reduction after the application of normal stress. The vertical force applied can induce the collapse of structures formed by cohesive interparticle forces with a consequent reduction in volume and increase in density (46) . On the other hand, powders presenting good flowability are able to form a very dense packing, less sensitive to volume reduction after normal stress application. The higher compressibility of EXP 4 granules can be related to the higher cohesion between the particles, since the FRI presents an average value of 1.39, very close to the value of FRI obtained for the unprocessed materials. Unexpectedly, the EXP 1 granules have shown higher compressibility-approximately 50% more at 15 kPa of normal stress applied-than EXP 3 granules even though EXP1 granules have a lower FRI. However, the SI for EXP 1 granules provides evidence of possible attrition/ deagglomeration of the granules when submitted to stress, which can result in a reduction of the particle size and, consequently, have an impact on the volume reduction during the compressibility assay. Top-down powder flow property is governed by the opposing effects of interparticle forces and gravitational force. Powders or granules with poor flow properties exhibit strong interparticle forces and/or weak gravitional force. The interparticle forces can be measured by quantifying the load required to induce flow, i.e. the unconfined yield strength (σ c ), or, for bulk solid at a specific consolidation state, the major principal stress (σ 1 ). The flowability index (ffc = σ 1 /σ c ), which is a measure of good powder flow properties, is inversely related to the load required to induce flow at a specific consolidation stress. HPMC-MCC granules prepared in EXP 3 showed higher ffc, with very low cohesion and compressibility compared to the other experimental batches (p < 0.05) (Fig. 8a, b) . They also showed very low AIF (E), as did MCC-PVP granules prepared in EXP 4 (Fig. 8c) . For an ideal axisymmetric flow property exhibiting identical powder flow patterns on different planes along similar axis, i.e. ideal powder flow from cylindrical-conical shape hoppers, bulk solids should exhibit low cohesive strength, high ffc, and should not consolidate appreciably (i.e. have low compressibility), such that gravitional force can overcome interparticle forces to induce mass flow from the hopper. In this respect, HPMC-MCC granules prepared in EXP 3 showed superior powder flow properties compared to the other batches.
CONCLUSION
Fluidized bed granulation has been shown to represent a useful tool to produce pharmaceutical granules containing cocrystals in a one-step process. The DAP-CAF in situ cocrystallization during the process was observed after the dissolution of the API and coformer in the liquid phase and subsequent spraying onto the fluidized solid phase. The presence of polymers in the liquid phase reduced the possibility of cocrystallization due to the interaction of the binder with the cocrystal components. However, the resultant amorphous form of the API in the presence of polymers could represent a platform technology whereby amorphous solid dispersions may be produced in a granulate form. Differences in mechanical properties were found between the amorphous and crystalline granules, with amorphous materials showing greater compressibility than crystalline granules. The suitability of the system for the production of large batches of cocrystal granules represents a great advantage over other manufacturing methods.
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